Literature DB >> 7690560

Vascular smooth muscle cells as target for estrogen.

A Orimo1, S Inoue, A Ikegami, T Hosoi, M Akishita, Y Ouchi, M Muramatsu, H Orimo.   

Abstract

ER mRNA was detected as 6.0 kb band by Northern blot analysis in vascular smooth muscle cells (VSMC) derived from rat aorta. The presence of ER mRNA in VSMC was confirmed by reverse transcriptase-polymerase chain reaction using specific primers for rat ER cDNA. In addition, the immunocytochemistry of ER was performed in VSMC using a monoclonal anti-ER antibody which recognizes DNA-binding domain of ER. The immunoreactivity was distributed in the cytoplasm as well as in the nuclei. Thus, the expression of ER in VSMC was demonstrated at both the protein and the mRNA level. Furthermore, the expression of c-fos mRNA in VSMC was found up-regulated by 17 beta-estradiol treatment within 30 min. The observation that VSMC possess ER and respond to estrogen supports the idea that estrogen may directly influence vascular cell system through the ER.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690560     DOI: 10.1006/bbrc.1993.2106

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Serotonin (5-HT) stimulates thyrotropin-releasing hormone (TRH) gene transcription in rat embryonic cardiomyocytes.

Authors:  Z X Shi; W Xu; M K Selmanoff; J F Wilber
Journal:  Endocrine       Date:  1997-04       Impact factor: 3.633

2.  Voltage-activated Ca(2+) channels and their role in the endocrine function of the pituitary gland in newborn and adult mice.

Authors:  Simon Sedej; Tetsuhiro Tsujimoto; Robert Zorec; Marjan Rupnik
Journal:  J Physiol       Date:  2004-01-14       Impact factor: 5.182

Review 3.  Estrogen receptor-α and estrogen receptor-β in the uterine vascular endothelium during pregnancy: functional implications for regulating uterine blood flow.

Authors:  Mayra B Pastore; Sheikh O Jobe; Jayanth Ramadoss; Ronald R Magness
Journal:  Semin Reprod Med       Date:  2012-01-23       Impact factor: 1.303

4.  Estradiol attenuates directed migration of vascular smooth muscle cells in vitro.

Authors:  F D Kolodgie; A Jacob; P S Wilson; G C Carlson; A Farb; A Verma; R Virmani
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

5.  Endothelial vasodilator production by ovine uterine and systemic arteries: ovarian steroid and pregnancy control of ERalpha and ERbeta levels.

Authors:  Michael J Byers; Amy Zangl; Terrance M Phernetton; Gladys Lopez; Dong-Bao Chen; Ronald R Magness
Journal:  J Physiol       Date:  2005-03-17       Impact factor: 5.182

6.  Isolation of estrogen-responsive genes with a CpG island library.

Authors:  T Watanabe; S Inoue; H Hiroi; A Orimo; H Kawashima; M Muramatsu
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

7.  [Regulation of uterine blood flow. I. Functions of estrogen and estrogen receptor α/β in the uterine vascular endothelium during pregnancy].

Authors:  Pastore R Mayra; Villalón L Rosalina; Gladys López; Jesús Iruretagoyena; Ronald Magness
Journal:  Rev Chil Obstet Ginecol       Date:  2014

8.  Identifying estrogen receptor alpha target genes using integrated computational genomics and chromatin immunoprecipitation microarray.

Authors:  Victor X Jin; Yu-Wei Leu; Sandya Liyanarachchi; Hao Sun; Meiyun Fan; Kenneth P Nephew; Tim H-M Huang; Ramana V Davuluri
Journal:  Nucleic Acids Res       Date:  2004-12-17       Impact factor: 16.971

9.  Transcriptional activation of insulin-like growth factor binding protein 6 by 17beta-estradiol in SaOS-2 cells.

Authors:  Yu-yan Zhao; Lei Guo; Xiao-juan Zhao; Hong Liu; Tian Lei; Dong-jie Ma; Xiao-yu Gao
Journal:  Exp Mol Med       Date:  2009-07-31       Impact factor: 8.718

10.  Growth factor activation of the estrogen receptor in vascular cells occurs via a mitogen-activated protein kinase-independent pathway.

Authors:  R H Karas; E A Gauer; H E Bieber; W E Baur; M E Mendelsohn
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.